Posts Tagged “Uruguay”
On April 28 2018 the Office of the United States Trade Representative (USTR) issued its Special 301 Report, which is the result of:
“an annual review of the state of IP protection and enforcement in U.S. trading partners around the world, which the Office of the United States Trade Representative (USTR) conducts pursuant to Section 182 of the Trade Act of 1974, as amended by the Omnibus Trade and Competitiveness Act of 1988, the Uruguay Round Agreements Act, and the Trade Facilitation and Trade Enforcement Act of 2015 (19 U.S.C. § 2242).“(1)
Section I.A.1 of the report concerns pharmaceutical and medical device innovation and market access and:
calls on Mexico – as a US trading partner – to address pharmaceutical and medical device IP-related challenges; lists the steps that it can take in order to open its markets to IP-intensive pharmaceutical products and medical devices; and encourages it to recognise the value of innovation in these fields and contribute its fair share to the research and development of new treatments and cures.
Whereas Mexico has a relatively strong IP protection system for pharmaceutical products (which includes broad criteria on patentable subject matter, linkage between patents and marketing authorisations and limited…
The European Union (EU) is currently negotiating a free trade agreement (FTA) with the four founding members of Mercosur (Argentina, Brazil, Paraguay and Uruguay), which comprises a chapter on intellectual property rights (IPR). A new round of negotiations is taking place from November 29th to December 8th in Brussels. Word is that they aim to announce the closure of the agreement at the next World Trade Organization (WTO) Ministerial Conference that will be held from 10-13 of December in Buenos Aires and the clock is ticking to close all the chapters before that. As usual, the negotiations are taking place in secrecy, but the EU released a draft proposal of the IPR chapter in September last year, which has provided the general public some knowledge about what is been negotiated.
Throughout the many years of negotiations, the Mercosur countries have been opposing the adoption of any clauses that provide further protection for IPR than is already required in the WTO TRIPS Agreement. However, according to recent press reports the EU is still pushing for those measures. It is suspected that they are deliberately delaying the issue of patents and public health to try to force an agreement at the last minute, when negotiations…